Keith G. Mansfield

14.1k total citations
161 papers, 7.6k citations indexed

About

Keith G. Mansfield is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Keith G. Mansfield has authored 161 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Virology, 57 papers in Epidemiology and 55 papers in Infectious Diseases. Recurrent topics in Keith G. Mansfield's work include HIV Research and Treatment (60 papers), Immune Cell Function and Interaction (23 papers) and Herpesvirus Infections and Treatments (23 papers). Keith G. Mansfield is often cited by papers focused on HIV Research and Treatment (60 papers), Immune Cell Function and Interaction (23 papers) and Herpesvirus Infections and Treatments (23 papers). Keith G. Mansfield collaborates with scholars based in United States, Switzerland and United Kingdom. Keith G. Mansfield's co-authors include Andrew A. Lackner, Angela Carville, Angela Carville, Dan H. Barouch, Diana M. Lynch, Peter Abbink, Lynn M. Wachtman, Ronald C. Desrosiers, Jaap Goudsmit and Menzo Havenga and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Keith G. Mansfield

161 papers receiving 7.5k citations

Peers

Keith G. Mansfield
Shigeru Morikawa Japan
Xavier Álvarez United States
François Villinger United States
Kazuyoshi Ikuta Japan
Satya Dandekar United States
Vincent Piguet Canada
Christopher M. Walker United States
Roger Le Grand France
Michael K. Axthelm United States
Zhen F. Fu China
Shigeru Morikawa Japan
Keith G. Mansfield
Citations per year, relative to Keith G. Mansfield Keith G. Mansfield (= 1×) peers Shigeru Morikawa

Countries citing papers authored by Keith G. Mansfield

Since Specialization
Citations

This map shows the geographic impact of Keith G. Mansfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith G. Mansfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith G. Mansfield more than expected).

Fields of papers citing papers by Keith G. Mansfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith G. Mansfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith G. Mansfield. The network helps show where Keith G. Mansfield may publish in the future.

Co-authorship network of co-authors of Keith G. Mansfield

This figure shows the co-authorship network connecting the top 25 collaborators of Keith G. Mansfield. A scholar is included among the top collaborators of Keith G. Mansfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith G. Mansfield. Keith G. Mansfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sejersen, Thomas, Hildegard Büning, Michael Rothe, et al.. (2025). Pilocytic astrocytoma in a child with spinal muscular atrophy treated with onasemnogene abeparvovec. Molecular Therapy. 33(6). 2842–2850. 2 indexed citations
2.
Tiwari, Nishant, Jennifer Vaughn, Saunder Bernes, et al.. (2023). Epithelioid neoplasm of the spinal cord in a child with spinal muscular atrophy treated with onasemnogene abeparvovec. Molecular Therapy. 31(10). 2991–2998. 18 indexed citations
3.
Meseck, Emily K., et al.. (2022). Intrathecal sc-AAV9-CB-GFP: Systemic Distribution Predominates Following Single-Dose Administration in Cynomolgus Macaques. Toxicologic Pathology. 50(4). 415–431. 24 indexed citations
4.
Flandre, Thierry, Keith G. Mansfield, Pascal Espié, Tina Rubic-Schneider, & Peter Ulrich. (2022). Immunosuppression Profile of CFZ533 (Iscalimab), a Non-Depleting Anti-CD40 Antibody, and the Presence of Opportunistic Infections in a Rhesus Monkey Toxicology Study. Toxicologic Pathology. 50(5). 712–724. 4 indexed citations
5.
Tukov, F, Keith G. Mansfield, Mark Milton, et al.. (2022). Single-Dose Intrathecal Dorsal Root Ganglia Toxicity of Onasemnogene Abeparvovec in Cynomolgus Monkeys. Human Gene Therapy. 33(13-14). 740–756. 28 indexed citations
6.
7.
Publicover, Jean, Anuj Gaggar, Ugur Halac, et al.. (2018). An OX40/OX40L interaction directs successful immunity to hepatitis B virus. Science Translational Medicine. 10(433). 34 indexed citations
8.
Mansfield, Keith G., et al.. (2011). Specific Pathogen-Free Status Alters Immunophenotype in Rhesus Macaques: Implications for the Study of Simian Immunodeficiency Virus. AIDS Research and Human Retroviruses. 27(10). 1033–1042. 2 indexed citations
9.
Liu, Jinyan, Brandon F. Keele, Hui Li, et al.. (2010). Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys. Journal of Virology. 84(19). 10406–10412. 88 indexed citations
10.
Alpert, Michael D., Andrew R. Rahmberg, William J. Neidermyer, et al.. (2010). Envelope-Modified Single-Cycle Simian Immunodeficiency Virus Selectively Enhances Antibody Responses and Partially Protects against Repeated, Low-Dose Vaginal Challenge. Journal of Virology. 84(20). 10748–10764. 9 indexed citations
11.
Barouch, Dan H., Jinyan Liu, Diana M. Lynch, et al.. (2009). Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine against Simian Immunodeficiency Virus Challenge in Rhesus Monkeys. Journal of Virology. 83(18). 9584–9590. 26 indexed citations
12.
Sasseville, Vito G. & Keith G. Mansfield. (2009). Overview of known non-human primate pathogens with potential to affect colonies used for toxicity testing. Journal of Immunotoxicology. 7(2). 79–92. 30 indexed citations
13.
Liu, Jinyan, Bonnie A. Ewald, Diana M. Lynch, et al.. (2008). Magnitude and Phenotype of Cellular Immune Responses Elicited by Recombinant Adenovirus Vectors and Heterologous Prime-Boost Regimens in Rhesus Monkeys. Journal of Virology. 82(10). 4844–4852. 90 indexed citations
14.
Mansfield, Keith G., Sabine M. Lang, Marie‐Claire Gauduin, et al.. (2008). Vaccine Protection by Live, Attenuated Simian Immunodeficiency Virus in the Absence of High-Titer Antibody Responses and High-Frequency Cellular Immune Responses Measurable in the Periphery. Journal of Virology. 82(8). 4135–4148. 42 indexed citations
15.
Westmoreland, Susan V. & Keith G. Mansfield. (2008). Comparative pathobiology of Kaposi sarcoma-associated herpesvirus and related primate rhadinoviruses.. PubMed. 58(1). 31–42. 21 indexed citations
16.
Permar, Sallie R., Helen H. Kang, Angela Carville, et al.. (2008). Potent Simian Immunodeficiency Virus-Specific Cellular Immune Responses in the Breast Milk of Simian Immunodeficiency Virus-Infected, Lactating Rhesus Monkeys. The Journal of Immunology. 181(5). 3643–3650. 20 indexed citations
17.
Stevceva, Liljana, Angela Carville, Beatriz Pacheco, et al.. (2008). The Efficacy of T Cell-Mediated Immune Responses Is Reduced by the Envelope Protein of the Chimeric HIV-1/SIV-KB9 Virus In Vivo. The Journal of Immunology. 181(8). 5510–5521. 12 indexed citations
18.
Wachtman, Lynn M., Lisa Gualtieri, C. A. Wanke, Richard P. Shannon, & Keith G. Mansfield. (2008). Viral and Host Correlates of Serum Resistin in Simian AIDS. AIDS Research and Human Retroviruses. 24(1). 34–42. 3 indexed citations
19.
Sasseville, Vito G., et al.. (2007). Naturally occurring Tyzzer's disease in cotton-top tamarins (Saguinus oedipus).. PubMed. 57(1). 125–7. 10 indexed citations
20.
Bertley, Frederic M.N., Pamela A. Kozlowski, Shainn-Wei Wang, et al.. (2004). Control of Simian/Human Immunodeficiency Virus Viremia and Disease Progression after IL-2-Augmented DNA-Modified Vaccinia Virus Ankara Nasal Vaccination in Nonhuman Primates. The Journal of Immunology. 172(6). 3745–3757. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigeru Morikawa Breakdown of academic impact, for papers by Xavier Álvarez Breakdown of academic impact, for papers by François Villinger Breakdown of academic impact, for papers by Kazuyoshi Ikuta Breakdown of academic impact, for papers by Satya Dandekar Breakdown of academic impact, for papers by Vincent Piguet Breakdown of academic impact, for papers by Christopher M. Walker Breakdown of academic impact, for papers by Roger Le Grand Breakdown of academic impact, for papers by Michael K. Axthelm Breakdown of academic impact, for papers by Zhen F. Fu
Rankless by CCL
2026